Company profile

Gour Medical specializes in the development and commercialization of innovative veterinary solutions for the management of the main pathologies of companion animals. Its unique positioning is based in particular on the use of natural products based on hemp extracts. Devoid of psychoactive effects, WEEDLEY, its first range of premium solutions, increases the effectiveness of cannabidiol thanks to the surround effect.

Source: Cofisem - Last Update: 28 Aug 2020
Key Executives
Chairman and Chief Executive Officer Serge Goldner
Business Development Director Marie Bénédicte Charpentier
Investor Relations Director Serge Goldner
VP, Financial Communication Edouard Maissin
Source: Cofisem - Last Update: 28 Aug 2020
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales
Consumed purchases
Personnal costs
Operating profit -131 -211
Income tax
Net income -146 -235 -370 -268 -102
Net consolidated income (Group share) -146 -235 -370 -268 -102
Fiscal year end 12.18 12.17 12.16 12.15 12.14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands CHF - thousands CHF - thousands CHF - thousands
Account Standards
Cost of sales 124
Operating income -346 -257 -102
Source: Cofisem - Last Update: 28 Aug 2020
Shareholder information
Serge Goldner 54.00 %
Free float 46.00 %
Source: Cofisem - Last Update: 28 Aug 2020

Address

Gour Medical

5 Rue de Castiglione
FR-75001 Paris
France
Phone number: +33 (0)1 42 46 11 73
Source: Cofisem - Last Update: 28 Aug 2020